Introduction
Lyme borreliosis is an arthropod-borne spirochaetal disease. Persons of all ages who engage in outdoor activities (occupational or recreational) are at risk. The highly endemic areas of North America are in Connecticut, New York, Massachusetts, New Jersey, Rhode Island, Minnesota and Wisconsin.' Exposure may be minimal, as in gardening or playing in the yard. The diagnosis of Lyme disease is based on the recognition ofclinical features of the illness in a patient with a history of possible exposure to the causative organism (a bite from a spirochaete-laden hard tick of the genus Ixodes).' An early expanding skin lesion erythema chronicum migrans (ECM), is the clinical hallmark. In the early stage skin involvement is often accompanied by flu-like symptoms (malaise and fatigue, headache, fever and chills, myalgia and arthralgia). 2 Thrombocytopaenia has not been reported in association with Lyme disease in the United States, although two patients with thrombocytopaenia and Lyme disease in Europe have been described.3 '4 We report six patients in whom this association was noted (Table I) At the time of the second hospital entry his temperature was 103TF. Laboratory examination was significant for the finding of thrombocytopaenia (platelet count 106 x 109/l). An ELISA (IgM, IgG) for Lyme disease was seropositive at 2.40 (normal range 0-0.9). A diagnosis of acute Lyme disease was made and complete recovery followed therapy with intravenous ceftriaxone.
Case S
A 78 year old man presented because of a skin rash and fever (temperature 104'F). A dermatology consultant described the rash as erythema chronicum migrans consistent with acute Lyme disease. Laboratory examination showed thrombocytopaenia (platelet count 70 x 109/1). A Lyme titre done on entry was negative. Therapy with doxycycline was begun. Three days later he was afebrile and his platelet count was 63 x 109/1. Ten days following discharge he had recovered completely and his platelet count was normal. 
Discussion
The occurrence of thrombocytopaenia in association with Lyme disease in the patient described in Case 1 prompted memory of a previous patient who had a similar clinical presentation (Case 3). As this association seemed unlikely to be a coincidence we were stimulated to review retrospectively our experience with Lyme disease. We were able to find four additional cases of this association.
The diagnosis of Lyme disease is made by the characteristic appearance of erythema chronicum migrans and a history of possible exposure to B. burgdorferi. In this setting serological confirmation is not needed. Although determination of specific antibody titres is a helpful adjunctive test, only a minority of patients with erythema migrans have detectable antibodies to B. burgdorferi at the time of presentation and if prompt antibody treatment is administered, seroconversion may not occur.
All six patients described in this report reside in a highly endemic area for Lyme disease in Northern Westchester County, New York. Patients 1 and 3 were both employed in jobs that required considerable outdoor exposure. The characteristic rash of Lyme disease (ECM) was noted upon initial examination of four patients (Case 1,3,5,6 ). The two other patients did not have the typical skin rash which either was overlooked or never occurred. Although the unique herald lesion of Lyme disease was not evident in these two subjects their serum samples were positive for antibodies to B. burgdorferi and the accompanying clinical symptoms and/or signs were consistent with those described for Lyme disease. A positive serodiagnosis of B. burgdorferi infection supported the clinical diagnosis in four of our six patients. (Antibodies to B. burgdorferi cross-react with Treponema palladium. All six patients had negative VDRL test results).
Although Lyme borreliosis is the most common arthropod-borne disease of North America and Europe, and its clinical and laboratory manifestations have been well described, the association of thrombocytopaenia with this tick-borne spirochaetal infection has received scant attention in the world literature.5 We were unable to find any reports of this association in the English language literature. 6 We were able to locate two brief case reports linking thrombocytopaenia to Lyme disease in the European literature.3'4
The six patients described in this report represent the first series of patients with coexistent thrombocytopaenia and Lyme disease. All patients had documented thrombocytopaenia during an illness characterized by clinical findings consistent with the diagnosis of Lyme disease. Bone marrow examination was done in Case 2 and the megakaryocytes were normal in number, maturation and morphology. The mean platelet volume (normal range 7.5-10.0 fl) of patients 2 and 6 was increased during the period ofthrombocytopaenia. With normalization of the platelet count the mean platelet volume decreased. These findings are consistent with increased platelet turnover and suggest either platelet consumption or destruction as a cause of the diminished levels of circulating platelets. It is known that the spirochete attaches itself to cell membrane glycoproteins called 'integrins'.7 Binding of the spirochete to platelet integrins could conceivably produce platelet damage which eventuates in removal of such platelets from the circulation. Although the marrow findings and the MPV measurements of the patient for whom these values were available support the notion of increased platelet destruction, the precise mechanism ofthe thrombocytopaenia occurring in these six patients cannot be ascertained from the information available in their hospital records.
Early diagnosis of Lyme disease and institution of appropriate therapy is important as it will significantly decrease the risk of later morbidity (chronic organ damage) which can occur when the disease is unrecognized and hence untreated. The presence of thrombocytopaenia in subjects in endemic areas presenting with a flu-like syndrome should heighten suspicion of Lyme disease (particularly when the pathognomonic rash is absent) and should prompt a more detailed history of possible tick bite and/or objective signs or laboratory findings of Lyme disease.
